Kenneth Allen Myszkowski Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 1 day ago
Kenneth Allen Myszkowski has an estimated net worth of at least $15.1 million*, as of Dec. 18, 2024. They own 400,600 shares of ARWR stock. They have sold 141,729 shares of ARWR stock since 2021, for an estimated $6.2 million.
Kenneth Allen Myszkowski $ARWR SEC Form 4 Insider Trading
Kenneth Allen Myszkowski has filed a total of 10 insider trades in $ARWR since 2021. Their most recent trade was a sale of 40,000 shares, made on Mar 06, 2024. Their largest trade was a sale of 40,000 shares, made on Mar 06, 2024. We estimate that they now own 400,600 shares of $ARWR, worth an estimated $8.8 million.
Insider Trading at $ARWR
There have been a total of 146 insider trades reported at $ARWR since 2021, with 3,655 shares purchased and 1.1 million shares sold. The most active insider traders in $ARWR stock have been Christopher Richard Anzalone, Patrick O'Brien, and Kenneth Allen Myszkowski. The most recent trade was a sale of 12,563 shares reported by Christopher Richard Anzalone (Chief Executive Officer), made on Dec 23, 2024.
History of Insider Stock Trades by Kenneth Allen Myszkowski
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ARWR
|
Sale | 40,000 | Mar 06, 2024 | March 8, 2024, 6:54 p.m. |
|
ARWR
|
Sale | 1,400 | Jan 05, 2024 | Jan. 8, 2024, 6:16 p.m. |
|
ARWR
|
Sale | 8,904 | Jan 05, 2024 | Jan. 8, 2024, 6:16 p.m. |
|
ARWR
|
Sale | 5,800 | Jan 05, 2024 | Jan. 8, 2024, 6:16 p.m. |
|
ARWR
|
Sale | 15,000 | Jun 27, 2023 | June 29, 2023, 6:41 p.m. |
|
ARWR
|
Sale | 30,625 | Dec 29, 2022 | Dec. 30, 2022, 6:12 p.m. |
|
ARWR
|
Sale | 15,908 | Jan 05, 2022 | Jan. 5, 2022, 8 p.m. |
|
ARWR
|
Sale | 3,786 | Jan 05, 2022 | Jan. 5, 2022, 8 p.m. |
|
ARWR
|
Sale | 3,778 | Jan 05, 2022 | Jan. 5, 2022, 8 p.m. |
|
ARWR
|
Sale | 16,528 | Jan 05, 2022 | Jan. 5, 2022, 8 p.m. |
$ARWR Executives and Stock Owners with Insider Trades
-
Christopher Richard Anzalone, Chief Executive Officer
-
Patrick O'Brien, COO and General Counsel
-
Kenneth Allen Myszkowski, Chief Financial Officer
-
Martin Javier San, Chief Medical Officer
-
Patrick O'Brien, General Counsel
-
James C Hamilton, Chief Discovery/Trans Medicine
-
Tracie Oliver, Chief Commercial Officer
-
James Hassard, Chief Commercial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.